FDA Approved: ZAVZPRET — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for ZAVZPRET (zavegepant) submitted by Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• ZAVZPRET (zavegepant)

Snippet

SUPPL AP for ZAVZPRET (ZAVEGEPANT)